Takeda proposes sale of Shire drug to gain European approval

Takeda Pharmaceutical Co Ltd has proposed to European regulators it could sell a Shire treatment in development due to concerns of overlap in inflammatory bowel disease treatments and its own drug Entyvio as it seeks clearance for the two companies' merger.

from Reuters: Health https://ift.tt/2CNenTt
via IFTTT

• Tweet
• Share
• Share
• Share
• Share